PA
CELG

Parallel Advisors’s Celgene Corp CELG Stock Holding History

Parallel Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,155
Closed -$710K – 2589
2019
Q3 		$710K Sell
7,155
-956
-12% -$90.8K 0.06% 217
2019
Q2 		$750K Sell
8,111
-862
-10% -$81.9K 0.07% 187
2019
Q1 		$847K Sell
8,973
-3,547
-28% -$310K 0.1% 159
2018
Q4 		$802K Buy
12,520
+8,877
+244% +$655K 0.11% 136
2018
Q3 		$326K Buy
3,643
+256
+8% +$22.6K 0.04% 283
2018
Q2 		$268K Sell
3,387
-367
-10% -$30.5K 0.04% 283
2018
Q1 		$335K Buy
3,754
+757
+25% +$72.7K 0.05% 237
2017
Q4 		$313K Sell
2,997
-440
-13% -$49.6K 0.05% 245
2017
Q3 		$348K Sell
3,437
-535
-13% -$72.9K 0.06% 223
2017
Q2 		$538K Buy
3,972
+576
+17% +$70.6K 0.1% 154
2017
Q1 		$419K Sell
3,396
-423
-11% -$50.6K 0.08% 175
2016
Q4 		$442K Buy
+3,819
New +$425K 0.1% 146

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Parallel Advisors's CELG Position: Q4 2019 in Review

Parallel Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,155 shares — an estimated $710K sold.

Parallel Advisors first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $847K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Parallel Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Parallel Advisors sold 7,155 Celgene Corp shares in Q4 2019, an estimated $710K.
  • Parallel Advisors first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • Parallel Advisors's Celgene Corp position peaked at $847K in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Parallel Advisors's 13F filing for Q4 2019, filed 30 Jan 2020.